Maximizing Outcomes in Relapsed/Refractory Multiple Myeloma: Tailoring Bispecific Antibody Approaches : Episode 4

Handling Dose Modifications and Treatment Interruptions Due to AEs With Bispecifics

January 31, 2025

Opinion

Video

Dr Mohan discusses with Nurse Distaso and Dr Nadeem approaches to handling dose modifications or treatment interruptions due to adverse events (AEs), including experiences where these adjustments significantly impacted patient outcomes.

EP: 1.John’s Journey with R/R MM

EP: 2.Patient Education: Preparing Patients for Bispecific Treatment in R/R MM

EP: 3.Managing and Monitoring Infections and Neurological Toxicities in Patients Receiving Bispecific Therapies

Now Viewing

EP: 4.Handling Dose Modifications and Treatment Interruptions Due to AEs With Bispecifics

EP: 5.Multidisciplinary Approaches to Managing AEs with Bispecifics

EP: 6.Eva’s Treatment Journey with R/R MM

EP: 7.Referring Patients on Bispecific Therapy: Initial Steps

EP: 8.Referral Process: Best Practices for Clear Communication

EP: 9.Referral Process With Bispecifics: Challenges and Support

Video content above is prompted by the following:

How do you handle dose modifications or treatment interruptions due to AEs?
- Can you share any experiences where such modifications significantly impacted patient outcomes?

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!